Form 4 Tracker
Karen A Dawes

Director · 2 filings · Latest: Sep 9, 2026

Barinthus Biotherapeutics plc.
REPLIGEN CORP
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RGEN
DAWES KAREN A—Dec 17, 2025
Proposed Sale
$161.00275$44.3K—